We are working with Guy’s and St. Thomas’ NHS Foundation Trust to produce national standardised SACT regimen-specific consent forms. We want to support clinicians in ensuring all patients are fully ...

as first-line treatment for stage IV or recurrent NSCLC (LBA53) BMS is initiating the Phase 3 RELATIVITY-1093 trial evaluating the fixed-dose combination of nivolumab and relatlimab (FDC 1:1 ...

open-label trial enrolled adults with stage IV clear-cell renal-cell carcinoma who had disease progression after treatment with immunotherapy and a VEGFR-TKI and randomized them (1:1) to belzutifan ...

Washington DC: On September 6, the Executive Board of the International Monetary Fund (IMF) concluded the 2024 Article IV Consultation [1] with Uganda. Uganda has navigated the post-pandemic recovery ...

As evident from the name itself, Agni-IV is fourth in the Agni series of medium to intercontinental range ballistic missiles developed by the Defence Research and Development Organisation (DRDO).